- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: gemcitabine/nab-paclitaxel
Total 8487 results
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Unresectable Pancreatic CarcinomaUnited States
-
Washington University School of MedicineCelgeneTerminatedCord CompressionUnited States
-
RenovoRxRecruitingLocally Advanced Pancreatic CancerUnited States, Belgium
-
Dana-Farber Cancer InstituteAVEO Pharmaceuticals, Inc.CompletedPancreatic CancerUnited States
-
Pharmacyclics LLC.CompletedMetastatic Pancreatic AdenocarcinomaSpain, Italy, Korea, Republic of, United States, Belgium, United Kingdom, Germany, France
-
CelgeneTerminatedPancreatic Neoplasms | CholestasisUnited States, Germany
-
Incyte CorporationTerminatedBreast Cancer | Pancreatic Cancer | Hodgkin's Lymphoma | Solid Tumor | Metastatic Cancer | Advanced Cancer | NHL (Non-Hodgkin Lymphoma) | UC (Ureter and Urethera)United States
-
M.D. Anderson Cancer CenterCompleted
-
Tianjin Medical University Cancer Institute and...Not yet recruitingPDAC - Pancreatic Ductal Adenocarcinoma
-
AstraZenecaCompletedMetastatic Pancreatic Ductal AdenocarcinomaUnited States, United Kingdom
-
Hao LongRecruitingChemotherapy | Safety | Biomarker | TislelizumabChina
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
NestléCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Fudan UniversityNot yet recruitingPancreatic Cancer
-
Bruno BockornyDana-Farber Cancer Institute; Agenus Inc.Not yet recruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Advanced Pancreatic Ductal AdenocarcinomaUnited States
-
FibroGenCompletedPancreatic Cancer (Unresectable)United States
-
OncoMed Pharmaceuticals, Inc.Completed
-
Eli Lilly and CompanyCompletedMetastatic Pancreatic CancerUnited States, Spain, Germany
-
AIO-Studien-gGmbHCompletedAdenocarcinoma PancreasGermany
-
Fudan UniversityUnknownStage IA Pancreatic Adenocarcinoma | Stage IB Pancreatic Adenocarcinoma | Stage IIA Pancreatic Adenocarcinoma | Stage IIB Pancreatic AdenocarcinomaChina
-
Merrimack PharmaceuticalsCompletedPancreatic CancerUnited States, Canada, Spain, Poland, United Kingdom, Germany
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedTesticular Germ Cell Tumor | Ovarian CancerUnited States, South Africa
-
University of WashingtonNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer | Skin MetastasesUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingLocally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy | Borderline Resectable Pancreatic Cancer Treated With ChemoradiotherapyUnited States
-
Tongji HospitalSun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Qilu... and other collaboratorsNot yet recruiting
-
Zhejiang Cancer HospitalSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityCompletedEsophageal Squamous Cell CarcinomaChina
-
Fudan UniversityNot yet recruitingPancreatic NeoplasmsChina
-
Daewoong Pharmaceutical Co. LTD.Active, not recruitingHepatitis B, ChronicKorea, Republic of
-
Lu Wang, MD, PhDRecruitingGallbladder Cancer | Initially Unresectable | the First Line TreatmentChina
-
Gilead SciencesRecruitingTriple Negative Breast Cancer | PD-L1 NegativeUnited States, Hong Kong, Belgium, Australia, Austria, Israel, Spain, Korea, Republic of, Taiwan, China, Japan, Netherlands, Brazil, Canada, Turkey, France, Germany, Malaysia, United Kingdom, Singapore, Hungary, Mexico, Italy, Switzer... and more
-
Sun Yat-sen UniversityActive, not recruitingNasopharyngeal CancerChina
-
M.D. Anderson Cancer CenterCompleted
-
CelgeneCompleted
-
Wake Forest University Health SciencesCelgeneCompletedLung CancerUnited States
-
Shanghai Jiaolian Drug Research and Development...Shanghai Pharmaceuticals Holding Co., LtdRecruitingTriple Negative Breast Cancer (TNBC)China
-
Tianjin Medical University Second HospitalRecruitingMuscle Invasive Bladder Cancer Urothelial CarcinomaChina
-
Spanish Breast Cancer Research GroupCelgeneCompleted
-
UNC Lineberger Comprehensive Cancer CenterCelgeneCompletedNon Small Cell Lung Cancer (NSCLC)United States
-
Icahn School of Medicine at Mount SinaiCelgene CorporationTerminated
-
Hellenic Oncology Research GroupCompletedStomach and Gastro-Esophageal Junction (GEJ) CancerGreece
-
Osaka Medical CollegeCompletedBreast Cancer | Effects of Chemotherapy | HER-2 Positive Breast CancerJapan
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
Women's Hospital School Of Medicine Zhejiang UniversitySun Yat-sen University; Qilu Hospital of Shandong University; Second Affiliated... and other collaboratorsRecruitingEpithelial Ovarian Carcinoma Stage III | Epithelial Ovarian Carcinoma Stage IV | Fallopian Tube Carcinoma Stage III | Fallopian Tube Carcinoma Stage IV | Primary Peritoneal Carcinoma Stage III | Primary Peritoneal Carcinoma Stage IVChina
-
Corcept TherapeuticsCompleted
-
German Breast GroupRoche Pharma AG; Celgene CorporationCompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
Acerta Pharma BVTerminatedMetastatic Pancreatic CancerUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
West Virginia UniversityCelgene CorporationWithdrawnNon-small Cell Lung CancerUnited States
-
Ohio State University Comprehensive Cancer CenterCelgene Corporation; National Comprehensive Cancer NetworkCompleted